Supplement labelling Poland compliance is not mainly a translation task—the more useful starting point is understanding that the label submitted with the GIS notification and the label printed on the product sold in stores are expected to match exactly. Label non-compliance is the single most frequent trigger for Chief Sanitary Inspectorate (Główny Inspektorat Sanitarny, GIS) explanatory proceedings and immediate product holds, and most failures trace back to a label that was treated as a design or marketing exercise rather than a legal document.
The mistake rarely appears at the notification stage. It surfaces later, when a GIS inspector compares the notified label against the product actually on the shelf, or when a mandatory Polish warning clause turns out to have been translated loosely rather than reproduced in the standard legal formula. By then, the printing runs are done, the stock is in the warehouse, and correcting the label means a hold on distribution while a relabelling exercise is arranged.
If you are still deciding the broader entry structure—entity setup, notification procedure, and advertising rules—start with our main guide on dietary supplements in Poland. This page focuses more narrowly on what Polish labelling law requires, what the common failure points are, and how a label audit fits into the notification workflow.
Table of Contents
- Legal Framework Governing Supplement Labelling in Poland
- Mandatory Elements Required on a Polish Supplement Label
- Language, Legibility, and Layout Rules
- Nutrition Declaration, Botanicals, and Daily Doses
- Health Claims and Medical Prohibitions (Regulation 1924/2006)
- Top Labelling Pitfalls That Trigger GIS Explanatory Proceedings
- How CGO Legal Audits and Approves Polish Supplement Labels
- FAQ – Supplement Labelling Poland
- Explore the Life Sciences & Healthcare Cluster
Legal Framework Governing Supplement Labelling in Poland
Supplement labelling in Poland sits at the intersection of EU and national rules, layered on top of one another rather than replacing each other.
- Regulation (EU) No 1169/2011 on the provision of food information to consumers (FIC Regulation) sets the EU-wide baseline: mandatory particulars, legibility standards, and the requirement that a Food Business Operator (FBO) established in the EU be identified as responsible for the label.
- The Act on Food Safety and Nutrition (Ustawa o bezpieczeństwie żywności i żywienia) of 25 August 2006 provides the Polish statutory basis for the dietary supplement category and the notification obligation tied to it.
- The Health Minister’s Regulation on the Composition and Labelling of Dietary Supplements (Rozporządzenie Ministra Zdrowia z dnia 9 października 2007 r. w sprawie składu oraz oznakowania suplementów diety, consolidated text Journal of Laws 2023, item 79, most recently amended in 2025) sets out the Poland-specific mandatory label content, permitted vitamin and mineral forms, and composition limits.
Responsibility for label accuracy rests with the Food Business Operator—the entity whose name and EU address appear on the packaging as responsible for the product information. This is the same entity that carries the GIS notification obligation, which is why a label audit and the notification filing should generally be treated as a single, coordinated workstream rather than two separate tasks handled by different teams.
Preparing a supplement label for the Polish market?
A label audit before printing or notification is the most efficient point in the process to catch mandatory wording gaps, legibility issues, and claim mismatches—before the distribution hold, not after.
Mandatory Elements Required on a Polish Supplement Label
A compliant Polish label must generally include the following elements, each carrying its own regulatory purpose and its own common failure point. These clauses follow standard formulas expected under the Health Minister’s Regulation, and departing from the accepted Polish wording is itself a common source of GIS queries, even where the underlying product is fully compliant.
| Mandatory Label Element | Polish Legal Wording / Standard | Regulatory Purpose | Common Compliance Error |
|---|---|---|---|
| Category name | “suplement diety” | Identifies the product as a food supplement, not a medicine or other category | Using “food supplement,” “prep,” or “vitamins” without the mandatory Polish category name |
| Diet substitution warning | Suplementy diety nie mogą być stosowane jako substytut (zamiennik) zróżnicowanej diety. | Prevents the product being presented as a replacement for balanced nutrition | Omitting the clause or translating it loosely instead of using the standard formula |
| Child safety warning | Suplementy diety powinny być przechowywane w sposób niedostępny dla małych dzieci. | Consumer safety, particularly for high-potency vitamin/mineral products | Warning present but not in the mandated Polish wording |
| Daily portion warning | Nie należy przekraczać zalecanej porcji do spożycia w ciągu dnia. | Prevents overdose from exceeding the recommended daily portion | Missing entirely, or portion size inconsistent with the notified composition |
| Composition declaration | Qualitative and quantitative list of active substances per daily portion | Enables GIS and consumers to verify content against permitted levels | Declared amounts not matching the batch sold, or missing chemical forms of vitamins/minerals |
| FBO identification | Name and EU/EEA address of the responsible entity | Establishes accountability under Regulation (EU) 1169/2011 | Listing a non-EU manufacturer address only, with no EU-established FBO |
| Recommended daily portion | Numeric portion (e.g., “1 capsule daily”) | Basis for nutrient declarations and dosage warnings | Portion size defined loosely (“as needed”) instead of a fixed daily amount |
Language, Legibility, and Layout Rules
The Polish-language requirement is absolute: any dietary supplement placed on the Polish market must carry a full Polish-language label, covering all mandatory particulars, not a partial translation of selected fields. A label can be multilingual, but the Polish version must be complete and stand on its own—consumers should not need to cross-reference another language version to find mandatory information.
Over-labelling (sticker labels) for imported products
For imported products, over-labelling (adding a Polish-language sticker to an otherwise foreign-language package) is a commonly used practical solution, but it is only compliant where the sticker itself carries the full set of mandatory Polish particulars, is securely affixed so it cannot be removed or altered, and does not obscure other mandatory information printed underneath. A partial sticker—covering only the product name or dosage while leaving warnings in the original language—is a frequent audit failure for imported stock.
Legibility: minimum x-height requirements
Legibility requirements under Regulation (EU) 1169/2011 set a minimum x-height (the height of lowercase letters, excluding ascenders and descenders) of 1.2 mm, reduced to 0.9 mm for packaging or containers with the largest surface area below 80 cm². Labels that meet the wording requirements but use undersized fonts to fit additional marketing text on small packaging remain a common and avoidable compliance gap.
Nutrition Declaration, Botanicals, and Daily Doses
Vitamin, mineral, and other active substance content must be declared in numeric form, expressed per the recommended daily portion set by the manufacturer—not per 100 g or 100 ml, which is the default for standard foods. Where relevant, the declaration should also express content as a percentage of the Reference Intake value (Referencyjna Wartość Spożycia, RWS, equivalent to the EU Nutrient Reference Value, NRV), giving consumers a point of comparison against typical daily needs.
For products containing botanical or plant-derived ingredients, best practice—and in many cases regulatory expectation—is to identify the Latin (scientific) name of the plant alongside the common name, and, where the ingredient is a standardized extract, to state the extraction ratio (Drug Extract Ratio, DER) and the standardization parameter (for example, the percentage of a named active compound). Vague botanical descriptions without species-level identification are a recurring point of GIS scrutiny, particularly for ingredients that sit close to the restricted or prohibited botanical lists maintained with input from the GIS Dietary Supplements Team.
Health Claims and Medical Prohibitions (Regulation 1924/2006)
Because a dietary supplement is legally a foodstuff, its label and packaging may not attribute to it the property of preventing, treating, or curing a human disease—doing so is both a mislabelling issue and a signal that risks reclassifying the product as a medicinal product. This prohibition applies regardless of how the claim is worded: explicit medical claims, implied claims through imagery (a stethoscope, a pharmacy cross, a “doctor recommended” badge), and disease-specific product naming can all trigger the same scrutiny.
Permitted nutrition and health claims are limited to those authorized on the EU Register of nutrition and health claims under Regulation (EC) 1924/2006. A number of claims relating to botanical substances remain formally “on hold” pending a final EU-level assessment, meaning they can generally continue to be used under transitional arrangements in some cases, but their status should be verified claim-by-claim rather than assumed. Using an unauthorized or “on-hold” claim incorrectly is one of the more common reasons a product crosses from routine notification into a borderline product dispute.
Reviewing health claims for a Polish supplement launch?
Claims that are lawful in one EU market are not automatically lawful in Poland if they fall outside the authorized EU register or imply a medicinal function. Our team cross-references marketing copy against the authorized claims list before launch.
Top Labelling Pitfalls That Trigger GIS Explanatory Proceedings
- Medical-style imagery or claims. Packaging graphics that visually suggest a pharmaceutical function—capsule imagery styled like medicine, clinical color schemes, or medical symbols—can prompt scrutiny independent of the wording used.
- Non-standardized Polish translations. Departing from the accepted Polish legal formulas for mandatory warnings, even where the meaning is preserved, is a common and avoidable source of GIS follow-up queries.
- Missing chemical forms of vitamins and minerals. The Health Minister’s Regulation specifies permitted chemical forms; a label listing only the vitamin or mineral name without the notified chemical form can create a mismatch with the GIS filing.
- Inconsistency between the notified label and the printed label. A label revised after notification—for a rebrand, packaging redesign, or claim update—without a corresponding update to the GIS filing is one of the most direct triggers for an explanatory proceeding, since GIS reviews compare the filed documentation against the product actually sold.
- Undersized or obscured mandatory text. Font sizes below the legal x-height minimum, or Polish-language stickers placed over other mandatory information, undermine an otherwise compliant label.
How CGO Legal Audits and Approves Polish Supplement Labels
Our Regulatory & Corporate practice supports foreign supplement brands through label compliance at the pre-launch stage, where corrections are straightforward, rather than after a GIS explanatory proceeding has already been opened.
On the pre-print side, we provide legal audits of label artwork, checking mandatory wording against the Polish legal formulas, composition declarations against the Health Minister’s Regulation, and font and legibility requirements under Regulation (EU) 1169/2011. We also handle health claims verification, cross-referencing marketing copy and packaging claims against the authorized EU claims register, and preparation of Polish-language label text and over-labelling stickers, using the standard legal formulas expected by GIS.
Where a label has already drawn a compliance query from the State Sanitary Inspection (Państwowa Inspekcja Sanitarna) or GIS directly, we provide representation before those authorities, including responses to information requests and, where necessary, support through the full explanatory proceeding.
Preparing to launch or relabel a supplement for the Polish market?
Our team can audit your artwork before it goes to print. A label review at the pre-print stage is the most efficient way to avoid a distribution hold after the stock is already in the warehouse.
FAQ – Supplement Labelling Poland
Explore the Life Sciences & Healthcare Cluster
This article covers supplement labelling requirements in Poland. For the broader regulatory framework, entity setup, and market entry overview, start with the main guide; for related operational topics, see the articles below.
- Dietary Supplements in Poland — main regulatory guide
- GIS Notification Guide — step-by-step electronic notification procedure
- Supplement Labelling Rules — current article
- Supplements vs Medicinal Products — borderline classification rules and URPL disputes
- Company Registration in Poland — Sp. z o.o. and branch formation
- VAT Registration in Poland — cross-border VAT compliance
Written by the Regulatory & Corporate Law Practice Team at CGO Legal | Last updated: July 2026
This article provides general information on dietary supplement labelling requirements in Poland and does not constitute legal advice. Label compliance is assessed on a case-by-case basis; foreign companies should have their specific artwork and claims reviewed before printing or notification.
